Effectiveness of estriol-containing vaginal pessaries and nitrofurantoin macrocrystal therapy in the prevention of recurrent urinary tract infection in postmenopausal women.
about
Oestrogens for preventing recurrent urinary tract infection in postmenopausal womenThe Female Urinary Microbiota/Microbiome: Clinical and Research Implications.Recurrent cystitis in non-pregnant women.[Primary and secondary prevention of urinary tract infections].The role of lactobacillus probiotics in the treatment or prevention of urogenital infections--a systematic review.Urinary tract infection in postmenopausal women.Diagnosis and management of recurrent urinary tract infections in non-pregnant women.Estrogenic modulation of uropathogenic Escherichia coli infection pathogenesis in a murine menopause model.Vaginal estrogen for genitourinary syndrome of menopause: a systematic review.The bladder is not sterile: History and current discoveries on the urinary microbiome.Vaginal microbiota and the use of probiotics.Recurrent urinary tract infections in healthy and nonpregnant womenRecurrent urinary tract infections among women: comparative effectiveness of 5 prevention and management strategies using a Markov chain Monte Carlo model.Urinary tract infections in postmenopausal women.Pharmacologic management of asymptomatic bacteriuria and urinary tract infections in women.The role of local estrogen therapy in the management of pelvic floor disorders.The urinary microbiota: a paradigm shift for bladder disorders?Long-term antibiotics for prevention of recurrent urinary tract infection in older adults: systematic review and meta-analysis of randomised trials.Antibiotic use during pregnancy and asthma in preschool children: the influence of confounding.[Prophylaxis of recurrent urinary tract infections].Vaginal microbial diversity among postmenopausal women with and without hormone replacement therapy.
P2860
Q24243182-605DF8EE-3994-40FB-B01B-7D028542E2EBQ33633384-B352976E-AE5A-44D8-A19E-94B683721932Q34011369-DE4771D9-D35C-4081-AAC0-3884E0D7F148Q34632416-0A572047-EBF5-420A-B670-9D119A302F3CQ34989914-B6B5B952-A5AD-4352-9CF0-73C4CFADADBFQ35635503-8AD7A804-34AA-41C5-B1B0-99451DFA7A2DQ36396956-8FEB00AB-C746-4B0F-B005-230774BCE3C4Q36646630-227BA637-DCA1-4E16-A71F-2DE6ED8BA332Q36865142-8E33C847-C34F-4D5E-9197-CF49423CFA21Q36895628-795F8647-35CF-4813-89EB-4C6175842E73Q37142995-60ACD43A-342B-4181-85F3-95AAB873C46AQ37152657-98B33C72-572F-4324-892E-4963A70E4E00Q37411685-0E7B15FA-E23F-4479-A6C2-FC0F94EFC768Q37682456-A12EAB85-7A0B-410A-AA71-7C6CC677846DQ37871043-1D3B5F06-7644-4CF4-95FB-171D008ACFB0Q38717871-638B0686-E756-4D29-BE9E-A5B1C7C7E7EFQ38845178-49EA7E00-CD77-4257-8E0C-32097A85D288Q39336781-3C271773-CBCE-4108-9937-0D677C01A369Q39782737-863689ED-E779-4FD4-B4EC-336B38A879D8Q41712298-23E822A9-F4B3-4AAB-93CF-49EAF3E53862Q46878336-AA152C90-8AF4-4146-A6E4-4975659847B6
P2860
Effectiveness of estriol-containing vaginal pessaries and nitrofurantoin macrocrystal therapy in the prevention of recurrent urinary tract infection in postmenopausal women.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Effectiveness of estriol-conta ...... ction in postmenopausal women.
@en
Effectiveness of estriol-conta ...... ction in postmenopausal women.
@nl
type
label
Effectiveness of estriol-conta ...... ction in postmenopausal women.
@en
Effectiveness of estriol-conta ...... ction in postmenopausal women.
@nl
prefLabel
Effectiveness of estriol-conta ...... ction in postmenopausal women.
@en
Effectiveness of estriol-conta ...... ction in postmenopausal women.
@nl
P2093
P2860
P356
P1476
Effectiveness of estriol-conta ...... ction in postmenopausal women.
@en
P2093
Colodner R
Rottensterich E
P2860
P304
P356
10.1086/374341
P407
P577
2003-05-21T00:00:00Z